NEW YORK, Jan. 12 /PRNewswire-USNewswire/ -- Innovations at the
intersection of medicine, biotechnology, engineering, physical
sciences and information technology are spurring new directions in
R&D, commercialization and technology transfer. Basic research in
nanomedicine and bionanotechnology is rapidly producing commercially
viable products. Governments and industries across the globe are
staking their claims by investing billions for research. Clearly,
international rivalries are growing and political alliances and battle
lines are beginning to gel.

The nanotech community will gather at ALM's Strategic Research
Institute's "2nd Annual NANOMEDICINE: Commercializing Drug Delivery,
Diagnostics and Medical Devices" conference for two days on March
26-27, 2007 in Arlington, VA to discuss the most important
applications of nanotechnology in drug delivery, diagnostics and
medical devices. The two-day event will consist of presentations,
panels and networking opportunities, providing insights into trends in
nanomedicine, dissociating myths from realities and highlighting
future areas of commercial potential. The previous conference was so
successful that a front-page lead cover story covering the conference
appeared in Genetic Engineering News.

The 2007 event will focus on cutting-edge R&D, commercialization
strategies, policy, regulatory and IP issues -- offering networking
opportunities to researchers from industry, government and academia;
physicians; intellectual property practitioners; business and economic
development professionals; technology transfer specialists, policy
makers and venture capitalists.

For more information on registration, potential speaking engagements,
or sponsorship/exhibition opportunities, please contact the organizer,
Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com
or call (212)967-0095 ext. 243. The conference website is
www.srinstitute.com/nano.

ABOUT STRATEGIC RESEARCH INSTITUTE

The Strategic Research Institute is part of ALM's Conference and Trade
Show Division, one of North America's largest producers of educational
and networking events for business leaders and the legal profession.
The division offers more than 300 conferences and two leading industry
tradeshows, as well as conferences in Europe and Asia. Attendance at
the division's events, which span a broad range of topics including
law, finance, natural resources, life sciences, multi-cultural
marketing, real estate and healthcare, will exceed 40,000
executive-level decision makers this year.

ABOUT ALM

Headquartered in New York City, ALM is a leading integrated media
company, focused on the legal and business communities. ALM currently
owns and publishes 37 national and regional magazines and newspapers,
including The American Lawyer(R), Corporate Counsel(R), The National
Law Journal(R) and Real Estate Forum(R). Other ALM businesses include
Law.com(R), the Web's leading legal news and information network, Law
Journal Press books, newsletter publishing, court verdict and
settlement reporting, production of professional educational seminars,
market research and content distribution. ALM was formed by U.S.
Equity Partners, L.P., a private equity fund sponsored by Wasserstein
& Co., LP. More information on ALM's businesses and services is
available on the Web at www.alm.com. SOURCE Strategic Research
Institute

-0- 01/12/2007